| Anderson AM, Bartlett JA
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection. [Journal Article, Review]
Expert Rev Anti Infect Ther 2005 Dec; 3(6):871-83.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Sosa N, Hill-Zabala C, Dejesus E, et al.
Abacavir and lamivudine fixed-dose combination tablet once daily compared with abacavir and lamivudine twice daily in HIV-infected patients over 48 weeks (ESS30008, SEAL). [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Acquir Immune Defic Syndr 2005 Dec 1; 40(4):422-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Two-once-daily fixed-dose NRTI combinations for HIV. [Journal Article]
Med Lett Drugs Ther 2005 Feb 28; 47(1203):19-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Treatment options for HIV, AIDS. [News]
FDA Consum 2004 Nov-Dec; 38(6):4.
Full Citation | Publisher Full Text | Find Related Articles |
| Berger DS
New once-a-day drugs: Truvada and Epzicom. [Newspaper Article]
Posit Aware 2004 Nov-Dec; 15(6):38-9.
Full Citation | Find Related Articles |
| James JS
FDA approves two combination pills, Epzicom and Truvada; comment on commercial race to once-a-day nucleosides. [Newspaper Article]
AIDS Treat News 2004 Jul 23; (403):6.
Abstract | Full Citation | Find Related Articles |
| FDA approves two combo brand-name AIDS drugs. [News]
Med Health 2004 Aug 9; 58(31):3-4.
Full Citation | Find Related Articles |
  |
